Condition
Pain
Pain is the nervous system's alarm, with nerves sending signals that the brain and spinal cord weigh and amplify, and chronic pain is when that alarm keeps sounding long after an injury should have settled. Among supplements, the one with findings so far is DSIP, a small peptide, and studies found chronic pain intensity went down. That rests on just four small studies with 35 people in total, so the evidence is limited.
Sources: PMID 6548970
- Updated
- How we grade
- 43 studies cited
- Supplements studied
- 0
- Medicines and peptides
- 1
- Graded outcomes
- 1
Prescription medicines and peptides studied, for context
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Chronic Pain Intensity Moderate Reduction | Improves (the measure goes down) | Moderate effect | 4 studies | 35 people | ||
What the published studies found
1 automated reading
Ginger (Zingiber officinale): pain
A Cochrane review (2016, 27 studies, 3,101 people) found an improvement in pain. That review studied women with primary or secondary dysmenorrhoea. 7 of the 9 studies read agree; 2 found no clear answer. The evidence is limited.
9 studies counted of 11 read: 9 reviews.
- Meta-analysis, 2016; 27 studies, 3,101 people; women with primary or secondary dysmenorrhoea: improves (the review the verdict rests on).
ginger (MD -1.55 points, 95% CI -2.43 to -0.68
Dietary supplements for dysmenorrhoea - Meta-analysis, 2024; 12 studies; women with primary dysmenorrhea: improves.
ginger is notably more effective than placebo in reducing both the intensity
Ginger for Pain Management in Primary Dysmenorrhea: A Systematic Review and Meta-Analysis - Meta-analysis, 2022; 3 studies, 330 people: improves.
Pain was the only clinical parameter that significantly decreased
A Meta-Analysis of the Impact of Nutritional Supplementation on Osteoarthritis Symptoms - Meta-analysis, 2021; 3 studies: improves.
reduced pain scores at 2 h (MD = -1.27
The efficacy of ginger for the treatment of migraine: A meta-analysis of randomized controlled studies - Meta-analysis, 2020; 4 studies; patients with knee osteoarthritis: unclear: evidence too weak to tell.
mean difference for pain was -7.88 mm
Effectiveness of Ginger on Pain and Function in Knee Osteoarthritis: A PRISMA Systematic Review and Meta-Analysis - Meta-analysis, 2019; 11 studies, 693 people; adults undergoing laparoscopic, obstetrical or cardiovascular surgeries: unclear: evidence too weak to tell.
reduction in the need for rescue medication for pain
Herbal medications for anxiety, depression, pain, nausea and vomiting related to preoperative surgical patients: a systematic review and meta-analysis of randomised controlled trials - Meta-analysis, 2016; 6 studies; women with dysmenorrhea: improves.
weighted mean difference on a 10 cm visual analogue scale was 1.55 cm
Efficacy of Oral Ginger (Zingiber officinale) for Dysmenorrhea: A Systematic Review and Meta-Analysis - Meta-analysis, 2015; 5 studies, 593 people; osteoarthritis patients aged over 18 years: improves.
statistically significant pain reduction SMD = -0.30
Efficacy and safety of ginger in osteoarthritis patients: a meta-analysis of randomized placebo-controlled trials - Systematic review, 2015; 7 studies; athletes and untrained individuals: improves.
modestly reduce muscle pain stemming from
Ginger (Zingiber officinale) as an Analgesic and Ergogenic Aid in Sport: A Systemic Review
- Meta-analysis, 2016; 27 studies, 3,101 people; women with primary or secondary dysmenorrhoea: improves (the review the verdict rests on).
Key findings
- Chronic Pain IntensityImproves (the measure goes down)
Shop the evidence-backed picks
The collection holds the supplements we grade A or B for its theme, in third-party tested products where the catalog has them. It opens in our Fullscript store. You can look through it without signing in; Fullscript asks for a free account to order.
We earn from purchases made in our Fullscript store, and links to Fullscript, iHerb or Thorne carry our referral, so we may earn a commission at no extra cost to you. Grades come from the research and never change based on what we earn. Full disclosure
Studies cited
43 studies from PubMed
- Effect of delta sleep-inducing peptide on the expression of antioxidant enzyme genes in the brain and blood of rats during physiological aging.
- Effect of delta sleep-inducing peptide on oxidative modification of proteins in rat tissues and blood during physiological aging.
- [Endogenous anticonvulsants: neuropeptide Y and delta sleep inducing peptide].
- Interaction of Delta sleep-inducing peptide and valproate on metaphit audiogenic seizure model in rats.
- Delta sleep-inducing peptide (DSIP): a still unresolved riddle
- Delta-sleep-inducing peptide potentiates anticonvulsive activity of valproate against metaphit-provoked audiogenic seizure in rats.
- Antiepileptic activity of delta sleep-inducing peptide and its analogue in metaphit-provoked seizures in rats.
- Delta sleep-inducing peptide and its tetrapeptide analogue alleviate severity of metaphit seizures.
- [Behavioral and electroencephalographic effects of delta sleep inducing peptide and its analogue on metaphit-induced audiogenic seizures in rats].
- Delta sleep inducing peptide (DSIP): effect on respiration activity in rat brain mitochondria and stress protective potency under experimental hypoxia
- Opioid detoxification with delta sleep-inducing peptide: results of an open clinical trial
- Delta-sleep-inducing peptide sequels in the mechanisms of resistance to emotional stress
- Delta sleep-inducing peptide administration does not influence growth hormone and prolactin secretion in normal women.
- [The delta sleep-inducing peptide and its role in modulating epileptic activity].
- Effects of delta sleep-inducing peptide on sleep of chronic insomniac patients. A double-blind study
- Immunohistochemical localization of delta sleep-inducing peptide-like immunoreactivity in the central nervous system and pituitary of the frog Rana ridibunda.
- Delta-sleep-inducing peptide stimulates melatonin, 5-methoxytryptophol and serotonin secretion from perifused rat pineal glands.
- Immunohistochemical localization of delta sleep-inducing peptide (DSIP) in the brain and pituitary of the cartilaginous fish Scyliorhinus canicula.
- Delta sleep-inducing-peptide-like immunoreactivity (DSIP-LI) and delta sleep in schizophrenic volunteers.
- Production and immunohistochemical application of monoclonal antibodies against delta sleep-inducing peptide.
- Immunoreactive delta sleep-inducing peptide in the rat hypothalamus, pituitary and adrenal gland: effects of adrenalectomy.
- Phosphorylation of delta sleep-inducing peptide (DSIP) by casein kinase II in vitro.
- Characterization of delta-sleep-inducing peptide-evoked release of Met-enkephalin from brain synaptosomes in rats.
- Immunohistochemical mapping of delta sleep-inducing peptide in the cat brain and hypophysis. Relationships with the LHRH system and corticotropes.
- Immunohistochemical distribution of delta sleep inducing peptide in the rabbit brain and hypophysis.
- Delta sleep-inducing peptide (DSIP)-like immunoreactivity in gut: coexistence with known peptide hormones.
- Involvement of spinal noradrenergic system in the mechanism of an antinociceptive effect of delta-sleep-inducing peptide (DSIP).
- Potent antinociceptive effect of centrally administered delta-sleep-inducing peptide (DSIP).
- Evidence for a role of delta sleep-inducing peptide in slow-wave sleep and sleep-related growth hormone release in the rat.
- DSIP--a tool for investigating the sleep onset mechanism: a review.
- Delta sleep-inducing peptide modulates the stimulation of rat pineal N-acetyltransferase activity by involving the alpha 1-adrenergic receptor
- Comparison of DSIP- (delta sleep-inducing peptide) and P-DSIP-like (phosphorylated) immunoreactivity in cerebrospinal fluid of patients with senile dementia of Alzheimer type, multi-infarct syndrome, communicating hydrocephalus and Parkinson's disease.
- The effects of DSIP on pain threshold during light and dark periods in rats are not naloxone-sensitive.
- Delta sleep-inducing peptide (DSIP) stimulates growth hormone (GH) release in the rat by hypothalamic and pituitary actions.
- Delta-sleep-inducing peptide (DSIP): a review
- DSIP in the treatment of withdrawal syndromes from alcohol and opiates
- A clinical trial with DSIP
- Therapeutic effects of delta-sleep-inducing peptide (DSIP) in patients with chronic, pronounced pain episodes. A clinical pilot study
- Successful treatment of withdrawal symptoms with delta sleep-inducing peptide, a neuropeptide with potential agonistic activity on opiate receptors
- Delta sleep-inducing peptide (DSIP)-like material is absorbed by the gastrointestinal tract of the neonatal rat.
- Acute and delayed effects of DSIP (delta sleep-inducing peptide) on human sleep behavior
- Radioimmunoassay of DSIP-like material in rat brain.
- Characterization of a delta-electroencephalogram (-sleep)-inducing peptide.